FIELD: medicine; pulmonology; therapy.
SUBSTANCE: invention can be used to assess the need for antibacterial therapy when a bacterial infection occurs in a patient with viral pneumonia. Scores are calculated based on the results of clinical blood test parameters. The following parameters of a clinical blood test are determined: leukocytes, neutrophils, lymphocytes, platelets, monocyte to lymphocyte ratio index in patients with viral pneumonia, as well as in cases where the diagnosis of pneumonia is confirmed, but a full etiological diagnosis is not possible. If the leukocyte value is more than 7.0×109/l 1 point is assigned, with a neutrophil value of more than 4.5×109/l 1 point is assigned, with a lymphocyte value of more than 1.7×109/l 1 point is assigned, if the platelet value is more than 208×109/l 1 point is assigned, if the index value of the ratio of monocytes to lymphocytes is less than 0.21 units 1 point assigned. If the total points are 0–1, there are no indications for prescribing antibacterial therapy. If the total points are 2–3, antibiotic therapy is indicated if the body temperature remains above 37.0°C for three days. If the total points are 4–5, antibiotic therapy is indicated.
EFFECT: method provides the possibility of timely prescription of antibacterial therapy in the event of a bacterial infection in a patient with viral pneumonia in the absence of the possibility of a full bacterial etiological diagnosis by determining the following parameters of a clinical blood test: leukocytes, neutrophils, lymphocytes, platelets and the monocyte to lymphocyte ratio index, with subsequent evaluation of the results according to declared scale.
1 cl, 2 dwg, 6 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR EARLY DIFFERENTIAL DIAGNOSIS OF VIRAL AND BACTERIAL COMMUNITY-ACQUIRED PNEUMONIA IN CHILDREN | 2022 |
|
RU2790239C1 |
METHOD OF EARLY PROGNOSIS OF THE NATURE OF THE COURSE OF ACUTE RESPIRATORY INFECTION IN CHILDREN | 2017 |
|
RU2659384C1 |
METHOD OF PREDICTING THE RISK OF DEATH FROM COVID-19 IN YOUNG PATIENTS | 2023 |
|
RU2803002C1 |
METHOD OF ASSESSING PATIENT'S CONDITION WITH MULTIPLE ORGAN FAILURE SYNDROME | 2022 |
|
RU2806155C1 |
METHOD OF TREATING CHILDREN WITH PNEUMONIA | 2008 |
|
RU2419444C2 |
METHOD OF PREDICTING EFFICIENCY OF ANTIRETROVIRAL THERAPY IN CASE IN HIV-INFECTION | 2009 |
|
RU2414858C1 |
METHOD OF TREATING CHRONIC DISEASES OF EAR-NOSE-THROAT ORGANS WITH VIRAL, BACTERIAL, AND MIXED VIRAL-BACTERIAL ETIOLOGY IN HIV-INFECTED CHILDREN AND ADOLESCENTS | 2004 |
|
RU2305558C2 |
METHOD OF EARLY DIAGNOSTICS OF VIRAL PNEUMONIA | 2010 |
|
RU2440577C1 |
INTEGRATED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA | 2008 |
|
RU2375060C1 |
METHOD FOR DIAGNOSIS OF INTRAUTERINE INFECTION IN NEWBORNS | 2002 |
|
RU2231791C2 |
Authors
Dates
2023-10-24—Published
2023-05-16—Filed